Stock Report

All about this stock under one free report Last Updated: 31-Aug-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Molecular Data - ADR Key Ratios

Stock Card factsheet share-fund-plan-icon

$0.00

up-down-arrow $0.00 (10.00%)

As on 08-Nov-2022 09:30EDT

Market cap

info icon

$5 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

0.5

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- -42.48 21.82 --
EBIT 0.00 66.69 -39.35 -213.46 --
Net Profit -- -- -69.49 -201.41 --
EPS -- -- 54.98 -- --
Book Value -- -- -- -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-20Dec-19
EBIT-Margin info -2.73-----4.14-1.43
Net Margin info ----------
Return on equity info 440.51----268.42139.18
Return on Capital info 385.31----533.17774.47
Return on Assets info -56.05--0.00-55.72-44.79
Debt to Equity (x) info ----0.00-2.55-0.23

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Molecular Data - ADR
--
533.17
774.47
-151.70
-98.24
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

--

--

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Molecular Data - ADR
--
268.42
139.18
913.93
-1,826.93
Peer Median
8.63
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

--

--

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Molecular Data - ADR
--
-55.72
-44.79
-67.66
-28.28
Peer Median
3.31
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

--

--

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Molecular Data - ADR
--
-4.14
-1.43
-2.60
-2.17
Peer Median
9.94
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

--

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Molecular Data - ADR
--
-4.32
-1.47
-2.81
-2.57
Peer Median
5.26
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

--

--

Year on year growth in net sales

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Molecular Data - ADR
--
-0.42
0.46
1.15
0.31
Peer Median
-2.22
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-39.35

Lower than Peers by 33.31

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Molecular Data - ADR
-39.35
-66.84
19.90
-158.95
13.76
Peer Median
-6.03
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

--

--

Year on year growth in profit after tax

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Molecular Data - ADR
--
-69.49
23.99
-136.20
5.38
Peer Median
-4.09
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

--

--

Year on year growth in earnings per share

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Molecular Data - ADR
--
0.55
-1.53
--
--
Peer Median
-2.06
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Molecular Data - ADR
--
-2.55
-0.23
-2.89
36.19
Peer Median
0.88
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

0.89

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Molecular Data - ADR
0.89
-1.84
-0.08
0.00
23.48
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

1.10

Lower than Peers by 0.52

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Molecular Data - ADR
1.10
0.96
0.72
1.44
1.26
Peer Median
1.62
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

1.09

Lower than Peers by 0.03

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Molecular Data - ADR
1.09
0.95
0.71
1.41
1.19
Peer Median
1.13
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Molecular Data - ADR
--
-29.35
-43.21
-12.37
-5.41
Peer Median
4.09
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

--

--

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Molecular Data - ADR
--
1.21
1.60
0.69
2.41
Peer Median
16.53
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

--

--

Sales / Average Total Assets

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Molecular Data - ADR
--
12.90
30.56
24.05
11.02
Peer Median
0.61
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Molecular Data - ADR
--
7.29
3.78
3.30
8.80
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Molecular Data - ADR
--
0.17
0.16
0.54
1.69
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Molecular Data - ADR
--
14.89
4.93
2.37
5.90
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-20
Dec-19
Dec-18
Dec-17
Molecular Data - ADR
--
-7.43
-0.99
1.47
4.59
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...